Ligands of Immunopharmacology

Mivotilate is a nontoxic, potent activator of the aryl hydrocarbon receptor (AhR) , and acts as a hepatoprotective agent.In VitroMivotilate is a nontoxic, potent activator of the aryl hydrocarbon receptor. Mivotilate (YH439) has a novel activation

Mivotilate is a nontoxic, potent activator of the aryl hydrocarbon receptor (AhR) , and acts as a hepatoprotective agent.In VitroMivotilate is a nontoxic, potent activator of the aryl hydrocarbon receptor. Mivotilate (YH439) has a novel activation

Mivotilate is a nontoxic, potent activator of the aryl hydrocarbon receptor (AhR) , and acts as a hepatoprotective agent.In VitroMivotilate is a nontoxic, potent activator of the aryl hydrocarbon receptor. Mivotilate (YH439) has a novel activation

Mivotilate is a nontoxic, potent activator of the aryl hydrocarbon receptor (AhR) , and acts as a hepatoprotective agent.In VitroMivotilate is a nontoxic, potent activator of the aryl hydrocarbon receptor. Mivotilate (YH439) has a novel activation

Mivotilate is a nontoxic, potent activator of the aryl hydrocarbon receptor (AhR) , and acts as a hepatoprotective agent.In VitroMivotilate is a nontoxic, potent activator of the aryl hydrocarbon receptor. Mivotilate (YH439) has a novel activation

MMG-11 quarterhydrate is a potent and selective human TLR2 antagonist with low cytotoxicity. MMG-11 quarterhydrate inhibits both TLR2/1 and TLR2/6 signaling with IC 50 s of 1.7 µM for Pam 3 CSK 4 -induced hTLR2/1 and 5.7 µM for Pam 2 CSK 4 -induced

Moracin C, a natural product, is an anti-inflammatory agent. Moracin C inhibits LPS-activated reactive oxygen species (ROS) and nitric oxide (NO) release from cellsIn VitroMoracin C (1-50 μM, 24 h) inhibits LPS-activated reactive oxygen species

Moracin C, a natural product, is an anti-inflammatory agent. Moracin C inhibits LPS-activated reactive oxygen species (ROS) and nitric oxide (NO) release from cellsIn VitroMoracin C (1-50 μM, 24 h) inhibits LPS-activated reactive oxygen species

MSA-2 dimer is a selective, orally active non-nucleotide STING agonist ( K d =145 μM) with long-term antitumor and immunogenic activity. MSA-2 dimer is bound to STING as a non-covalent dimer exhibiting higher permeability than cyclic dinucleotideIn

MSA-2 dimer is a selective, orally active non-nucleotide STING agonist ( K d =145 μM) with long-term antitumor and immunogenic activity. MSA-2 dimer is bound to STING as a non-covalent dimer exhibiting higher permeability than cyclic dinucleotideIn

N-deacetylated BMS-202 is the deacetylated of BMS-202. BMS-202 is an inhibitor of the PD-1/PD-L1 interaction, mainly used for cancer treatment.In VitroBMS-202 inhibits PD-1/PD-Ll interaction, and may augment therapeutic immune response to a number

N-deacetylated BMS-202 is the deacetylated of BMS-202. BMS-202 is an inhibitor of the PD-1/PD-L1 interaction, mainly used for cancer treatment.In VitroBMS-202 inhibits PD-1/PD-Ll interaction, and may augment therapeutic immune response to a number